Send the following on WhatsApp
Continue to Chathttps://www.zonebourse.com/cours/action/REVIVA-PHARMACEUTICALS-HO-118907069/actualite/Le-medicament-de-Reviva-Pharma-contre-la-schizophrenie-reussit-dans-une-etude-de-phase-tardive-45184662/?utm_source=whatsapp&utm_medium=social&utm_campaign=share